-
961
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung
Published 2021-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
962
Thanks to Reviewers
Published 2025-01-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
963
Acknowledging and addressing real-world challenges to treating immune-related adverse events
Published 2024-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
964
Utilization of primary tumor samples for cancer neoantigen discovery
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
965
Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcino...
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
966
Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
967
Differential impact of TIM-3 ligands on NK cell function
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
968
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
969
Urine proteomics defines an immune checkpoint-associated nephritis signature
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
970
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
971
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the Che...
Published 2024-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
972
Arginase-1-specific T cells target and modulate tumor-associated macrophages
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
973
Chemotherapy-induced cellular senescence promotes stemness of aggressive B-cell non-Hodgkin’s lymphoma via CCR7/ARHGAP18/IKBα signaling activation
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
974
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
975
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
976
Macrophage-inherited exosome excise tumor immunosuppression to expedite immune-activated ferroptosis
Published 2023-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
977
Methodological and conceptual considerations for examining the α-FAtE scoring in unresectable hepatocellular carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
978
Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy
Published 2024-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
979
B7-H3 CAR-T cell therapy combined with irradiation is effective in targeting bulk and radiation-resistant chordoma cancer cells
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
980
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y glo...
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article